In December 2011, the annual five-day San Antonio Breast Cancer Symposium presented the latest findings in breast cancer research to an international audience. Two large-scale, Phase III, international clinical trials of medications showed improved outcomes for patients, though as of conference dates both drugs still awaited FDA approval.
Other highlights from the conference include reports on the latest in laboratory-based breast cancer research, and results of other studies.
Also inside this issue:
- Save the date for JALBCA’s Annual Dinner: May 7, 2012
- Ellen P. Hermanson Foundation summer events announced
- FDA Advisory Panel decision about the use of bisphosphonates to prevent and treat osteoporosis
- Community resource list